specialty focus
The lure of the cure
NR: You recently wrote a piece for
The Monthly entitled ‘A New Theory of
Cancer’, in which you said you’ve tried to
go back and understand cancer from an
evolutionary standpoint. What did you
mean by that?
Leading scientists spearhead
radical rethink of cancer.
Paul Davies interviewed by Conor Burke
I
t is time to think of cancer as a chronic
disease and use cancer treatment as
something that manages the disease,
rather than eradicates it all together.
These ideas are part of a new theory put
forward by Professor Paul Davies and his
colleagues, forming part of a new ‘bottom
up’ approach to cancer theory.
A theoretical physicist by trade, with an
interest in cosmology and astrophysics,
Davies’ career more closely mirrors that of
the late physicist – and his friend– Stephen
Hawking, than that of an oncologist.
He was first approached to explore
cancer research by the deputy director of
the US National Cancer Institute, Dr Anna
Barker, in 2008, as she sought some ‘out of
the oncological box’ thinking.
This led to 12 new cancer centres
opening across the US, pairing physical
scientists with oncologists and precipitating
theories that viewed cancer through an
evolutionary prism and positing new
approaches to screening, as well as
potentially revolutionary ideas on treatment.
Nursing Review spoke with Davies to
find out more about this radical rethinking
of cancer.
18 | nursingreview.com.au
PD: It occurred to me at the outset when
I was thinking about the nature of cancer,
that something that is so stubborn, so
hard to treat, is unlikely to be just some
sort of recent aberration. It looks like
it’s deeply integrated into the nature of
multicellular life as part of, if you like, the
whole great life program. And evidence
for this soon came to my attention. People
of course dwell on human cancers, but
cancers are found pretty much right
across the tree of multicellular life. So all
mammals, birds, insects, fish, and even
plants, fungi and corals, have cancer or
cancer-like phenomena.
So, if you just take an evolutionary
perspective and ask, “Well, when did all
these species intersect into a common
ancestor?”, you’re basically going back to
the origin of multicellularity itself, which
occurred several times independently
between about 1.5 billion years ago and
600 million years ago. So, somewhere in
that window, the genetic apparatus or the
program that runs cancer or drives cancer
got incorporated into the genomes of pretty
much all of the organisms. So it’s something
that comes with multicellularity.
That’s not such a heretical idea, because
cancer is a disease of bodies, and bodies
didn’t exist before multicellularity. And
when you think about the way life is done
in multicellular organisms, there has to be
cooperation between the individual cells
in your body, what are called somatic cells,
and the body as a whole. The project of a
multicellular organism is to get its genes
into the next generation, and those genes
are conveyed through the germ line, like
the sperm and eggs, but the rest of the
body is a vehicle for that. But the DNA in
all of your cells is all the same. It can all
make a complete organism. It’s all got the
plan for the whole thing. But the somatic
cells have to cooperate, and they do divide,
maybe 30 or 40 times, but then they reach
a point where the body says that’s enough
and then they commit suicide, a process
called apoptosis.
So the price that the somatic cells of our
body pay for being part of this collective
project in multicellular organisms is suicide
– cell death. And cancer is a breaking of
that contract between the individual cells
and the body as a whole. It’s where somatic
cells say, “Well, I know I’m supposed to just
divide when I’m given instructions and then
I’m supposed to commit suicide when the
time comes, but I’m going to defy that and
break out on my own and make a bid for
immortality as life was two billion years ago.”
So it’s a throwback to a more primitive
and, in many cases, pre-multicellular type of
lifeform. That’s the basic idea.
When you started to break away from
traditional oncology and somatic
mutation theories, your problem was
the ability for those theories to predict
cancer. So you and your colleagues
looked at the age of genes is a means of
cancer prediction. Why?
There’s a new science which goes by the
frightening name of phylostratigraphy,
and what this basically means is you can
date genes. And you can compare the
homologues of a particular gene across
many species. So, you’ve got a gene for
hair colour, but you’ll find a similar gene in
other animals, and if you go further back,
you’ll find that there are genes quite close
to that in insects. So you can put an age on
any gene, including oncogenes – the genes
responsible for driving cancer.
We predicted that when you look at
the genes driving cancer and the genes
suppressing cancer – because the body
has evolved genes to do that – the tumour-
suppressor genes ought to be more recently
evolved, because tumours have only been a
feature of life in the last billion years or so.
I know this is a theoretical stage, but
are there other ideas as to how these
theories would be used practically
in screening?
Yes. At Arizona State University, my
geneticist colleague Kimberly Bussey took